Quest Laboratories
add_icon

Quest Laboratories

97.60
-3.75
(-3.70%)
Market Cap
₹159.94 Cr
PE Ratio
-
Volume
3,600.00
Day High - Low
₹97.60 - ₹96.40
52W High-Low
₹160.00 - ₹75.15
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
159.94 Cr
EPS
8.28
PB Ratio
-
Book Value
54.88
EBITDA
20.20
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
16.58
Debt to Equity
0.32
Forecast For
Actual
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,737.00
#1 4,16,764.48
40.16
#1 54,729.00
9.71
#1 10,980
2.89
41.99
6,496.50
1,72,461.66
69.16
9,712.00
18.67
2,191
35.10
54.95
3,834.30
1,29,770.14
60.40
11,539.40
6.99
1,911
30.46
64.03
1,496.30
1,20,864.24
22.30
28,409.50
7.12
5,291
3.71
43.36
1,265.80
1,05,645.41
18.66
33,741.20
16.73
5,725
-0.38
50.22
2,107.00
96,238.18
22.21
22,909.50
13.74
3,306
#1 72.75
58.72
917.80
92,352.16
#1 18.57
23,511.00
18.55
4,615
34.60
41.66
2,193.30
90,530.32
51.90
12,744.20
#1 20.90
2,007
-21.05
47.28
1,211.40
70,358.31
20.66
32,345.60
9.43
3,484
3.81
55.09
5,566.00
66,549.88
27.75
13,458.30
3.70
2,216
10.98
44.89

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
30.68 %
Net Income Growth
34.65 %
Cash Flow Change
-875.08 %
ROE
-52.91 %
ROCE
-53.80 %
EBITDA Margin (Avg.)
-2.04 %

Yearly Financial Results

Annual Financials
2021
2022
2023
2024
2025
TTM
Revenue
30
60
62
83
108
117
Expenses
29
53
54
67
88
98
EBITDA
2
7
8
16
20
19
Operating Profit %
5 %
11 %
13 %
19 %
15 %
16 %
Depreciation
0
1
1
1
1
1
Interest
0
0
1
1
1
2
Profit Before Tax
1
6
7
14
19
17
Tax
0
2
2
4
5
2
Net Profit
1
4
5
10
14
14
EPS in ₹
6.07
38.05
46.76
6.16
8.28
8.60

Balance Sheet

Balance Sheet
2021
2022
2023
2024
2025
Total Assets
18
35
47
61
122
Fixed Assets
6
7
10
10
12
Current Assets
12
27
34
50
107
Capital Work in Progress
0
0
0
0
0
Investments
0
0
0
7
52
Other Assets
13
27
37
44
58
Total Liabilities
18
35
47
61
122
Current Liabilities
11
23
29
30
37
Non Current Liabilities
2
2
3
2
3
Total Equity
6
10
15
29
82
Reserve & Surplus
5
9
14
17
65
Share Capital
1
1
1
12
16

Cash Flow

Cash Flow
2021
2022
2023
2024
2025
Net Cash Flow
-0
1
0
0
0
Investing Activities
-1
-2
-4
-5
-44
Operating Activities
1
4
4
3
-23
Financing Activities
0
-0
0
2
67

Share Holding

% Holding
Mar 2024
May 2024
Mar 2025
Sept 2025
Promoter
90.36 %
90.36 %
66.21 %
66.78 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
DIIs
0.00 %
0.00 %
0.07 %
0.00 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
24.35 %
25.50 %
Others
9.64 %
9.64 %
9.37 %
7.72 %
No of Share Holders
20
23
1,001
1,084

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
04 Sept 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
04 Sept 2024 126.50 126.80
14 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
14 Nov 2024 100.50 106.50
28 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 May 2025 101.45 100.00
24 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Jul 2025 92.95 107.75
13 Nov 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Nov 2025 86.05 88.65

Technical Indicators

RSI(14)
Neutral
57.73
ATR(14)
Less Volatile
4.44
STOCH(9,6)
Neutral
69.92
STOCH RSI(14)
Neutral
57.44
MACD(12,26)
Bullish
1.61
ADX(14)
Strong Trend
33.47
UO(9)
Bearish
56.39
ROC(12)
Uptrend And Accelerating
13.55
WillR(14)
Neutral
-53.53